A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
Public ClinicalTrials.gov record NCT02536833. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
Study identification
- NCT ID
- NCT02536833
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biosplice Therapeutics, Inc.
- Industry
- Enrollment
- 455 participants
Conditions and interventions
Conditions
Interventions
- SM04690 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 8, 2015
- Primary completion
- Apr 19, 2017
- Completion
- Apr 19, 2017
- Last update posted
- Mar 16, 2021
2015 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 22
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Phoenix | Arizona | 85029 | — |
| Research Site | Tucson | Arizona | 85712 | — |
| Research Site | El Cajon | California | 92020 | — |
| Research Site | Rancho Mirage | California | 92270 | — |
| Research Site | Spring Valley | California | 91978 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Clearwater | Florida | 33761 | — |
| Research Site | Coral Gables | Florida | 33134 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Miami | Florida | 33173 | — |
| Research Site | West Palm Beach | Florida | 33409 | — |
| Research Site | Woodstock | Georgia | 30189 | — |
| Research Site | Newton | Kansas | 67114 | — |
| Research Site | Wichita | Kansas | 67205 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Frederick | Maryland | 21702 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site 1 | St Louis | Missouri | 63141 | — |
| Research Site 2 | St Louis | Missouri | 63141 | — |
| Research Site | Orchard Park | New York | 14127 | — |
| Research Site | Rochester | New York | 14609 | — |
| Research Site | Raleigh | North Carolina | 27612 | — |
| Research Site | Salisbury | North Carolina | 28144 | — |
| Research Site | Cincinnati | Ohio | 45246 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Research Site | Rapid City | South Dakota | 57702 | — |
| Research Site | Knoxville | Tennessee | 37912 | — |
| Research Site | Austin | Texas | 78745 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | West Layton | Utah | 84041 | — |
| Research Site | Charlottesville | Virginia | 22911 | — |
| Research Site | Richmond | Virginia | 23225 | — |
| Research Site | Franklin | Wisconsin | 53132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02536833, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02536833 live on ClinicalTrials.gov.